Adbiotech Transitions to CEO Kim Dohyung’s Leadership... Accelerates Expansion into Bio and Digital Healthcare Sectors

Adbiotech is transitioning to a new leadership under CEO Kim Dohyung and will expand its business scope into the bio and digital healthcare sectors.

On June 19, Adbiotech announced that, along with the appointment of a new CEO, all major agenda items, including the addition of new business objectives, were approved as originally proposed at an extraordinary general shareholders’ meeting.

At the board meeting held on the same day, Kim Dohyung, CEO of Onheal, was appointed as the sole CEO of Adbiotech. Kim, a veterinarian-turned-executive, is known for founding and leading the growth of Notus (now HLB BioStep), a prominent domestic non-clinical contract research organization (CRO).

At this extraordinary general meeting, proposals to add new business objectives to pursue new areas—including bio research and development (R&D), medical and healthcare, animal healthcare, and digital platforms—were approved.

In addition, the appointment of new board members to execute the company’s mid- to long-term growth strategy was also approved. The newly appointed board includes CEO Kim as well as experts from the bio, investment, and management sectors.

Adbiotech plans to maintain its competitiveness in its existing immuno-antibody-based business while expanding its business portfolio, focusing on the bio and digital healthcare sectors. The company’s strategy is to build a sustainable growth foundation by strengthening its research and development capabilities and identifying new business opportunities.

A company representative stated, “This change in leadership and the shareholders’ meeting decisions are important turning points for business expansion and sustainable growth,” adding, “We will further advance our existing immuno-antibody business while broadening our scope into bio and digital healthcare to enhance corporate value.”

With the launch of CEO Kim Dohyung’s leadership, Adbiotech aims to strengthen its existing technological competitiveness and expand investments in new growth areas to secure mid- to long-term growth drivers.

This content was produced with the assistance of AI translation services.